Publications

5674 Results

Correlation between progesterone receptor (PgR) and response to tamoxifen in patients (PTS) with estrogen receptor (ER) positive newly diagnosed metastatic breast cancer. A Southwest Oncology Group study.

Authors
T Melink;S Green;B Metch;W McGuire;C Fabian;R Pugh;B Tranum;J Hill;CK Osborne
Journal / Conference
ASCO 9:53(#202)
Year
1990
Research Committee(s)
Breast
Study Number(s)
SWOG-8228

Immaturity and dyspoiesis scoring: A system to discriminate benign vs. malignant plasmacytic proliferation.

Authors
SM Saeed;BKS Raman;R Pohlod
Journal / Conference
Modern Pathology 3:1(514)
Year
1990
Research Committee(s)
Myeloma
Study Number(s)
SWOG-8229/30

Pooled results from three randomized adjuvant studies of doxorubicin versus observation in soft tissue sarcoma: 10 year results.

Authors
K Antman;L Ryan;E Borden;W Wood;H Lerner;J Corson;R Carey;H Suit;S Balcerzak;M Sherman;L Baker
Journal / Conference
ASCO 9:311(#1204)
Year
1990
Research Committee(s)
Sarcoma
Study Number(s)
SWOG-8291, SWOG-8391

Cisplatin (CDDP) and mitotane in metastatic adrenal carcinoma: A Southwest Oncology Group study.

Authors
RM Bukowski;J Montie;D Crawford;M Wolf
Journal / Conference
ASCO 9:136(#527)
Year
1990
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8325

Dose intensity is not associated with subsequent survival after adjustment for known prognostic factors in non-Hodgkin's lymphoma patients treated with m-BACOD, ProMace-CytaBOM, and MACOP-B on Southwest Oncology Group study.

Authors
S Dahlberg;TP Miller;B Dana;J Weick;RI Fisher
Journal / Conference
ASCO 9:225(#986)
Year
1990
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8410, SWOG-8503, SWOG-8508

Assessment of treatment costs for carboplatin and cisplatin.

Authors
E Hannigan;D Alberts;S Green;R O'Toole;N Mason-Liddil;E Surwit;D Stock-Novack;R Goldberg;V Malviya;W Nahhas;R Canetta;R Thomas
Journal / Conference
ASCO 9:337(#1305)
Year
1990
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-8412

Relationship between serum CA-125 levels at chemotherapy courses 3 and 6 and the outcome of second-look surgery status in advanced ovarian cancer.

Authors
DS Alberts;PY Liu;E Hannigan;EA Surwit;J O'Sullivan;D Garcia;M Richardson;S Williams;J Young;R O'Toole
Journal / Conference
AACR 31:189(#1121)
Year
1990
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-8412

Evaluation of "complete androgen blockade" (CAB) with flutamide (F) added to leuprolide (L) after progression on leuprolide (L) alone: Results of INT-0036 study in stage D2 cancer of the prostate (CP).

Authors
D McLeod;B Blumenstein;M Eisenberger;ED Crawford;D Spicer;J Spaulding;A Dorr;R Benson
Journal / Conference
ASCO 9:136(#526)
Year
1990
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8494 (INT-0036)

Intra-arterial cisplatin and radiation therapy in the management of high grade gliomas - results of SWOG-8510.

Authors
JE Mortimer;J Crowley
Journal / Conference
ASCO 9:90(#352)
Year
1990
Research Committee(s)
Brain
Study Number(s)
SWOG-8510

Advanced bladder cancer: A prospective intergroup trial comparing single agent cisplatin (CDDP) vs. M-VAC combination therapy (INT-0078).

Authors
PJ Loehrer;P Elson;JP Kuebler;ED Crawford;I Tannock;D Raghavan;R Stuart-Harris;D Trump;LH Einhorn
Journal / Conference
ASCO 9:132(#511)
Year
1990
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8594